VEGFA and hepatocellular carcinoma: Atezo-bev followed by TACE achieved a higher complete response rate than atezo-bev therapy alone.22) Atezo-bev exerts anti-VEGF effects before TACE, thereby enhancing the effects of TACE.22) There are various situations among intermediate-stage HCC, and the indications and timing for attempting conversion to curative therapy should be carefully considered.